No Data
Stock News Premium = The Growth Market will be (Delisted) for stocks with a Market Cap of less than 10 billion yen.
＜Currently, 70% of the stocks are affected, and the impact extends to IPOs＞ The Tokyo Stock Exchange has tightened the listing maintenance standards for the Growth Market and plans to delist companies that have not reached a Market Cap of 10 billion yen after five years of listing starting in 2030. Although there is still time until the deadline, 70% of the 612 listed stocks have a Market Cap of less than 10 billion yen, and the Emerging Markets, including IPOs, will enter a period of significant transformation. It has been noted that companies showcase impressive growth rates during their IPOs but deteriorate post-listing.
The USA's tariff "nuclear bomb" is coming! The Global manufacturing industry is trembling, and factory activities are shrinking in many regions.
Due to companies preparing to respond to the new round of tariffs in the USA, factory activities worldwide from Japan to the United Kingdom declined in March.
BOJ Governor Suggests Food Inflation Could Lead to Rate Hike -- Update
Strong performance, with dip buying favored due to the rise in US stocks.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to show a robust performance. Last weekend, on the 7th, the U.S. stock market saw the Dow Inc average rise by 222.64 dollars (+0.52%) to 42,801.72 dollars. Employment Statistics indicated some signs of a slowdown in employment, raising concerns about growth that weighed on stock prices. On the other hand, Federal Reserve Chair Powell reaffirmed in a speech that there are no issues with the economy and confirmed a stance of keeping policies steady for the time being, which supported the stock prices and expanded the gains towards the end of the session.
Japan skiing, Oncolis Bio and others.
A capital and business alliance agreement has been concluded with HUMEDIT, which handles various tests (NIPT/NI-PGS/PCR) such as the issuance of new stocks through third-party allocation (0.07 million3099 shares) and the disposal of treasury shares (0.18 million201 shares). ＜4584＞ Kids Bio had a large exercise of subscription rights (with price adjustment clauses) from the 24th, with the number of shares to be delivered starting from the 5th being 0.9 million shares. ＜4588＞ Oncolys Bio is conducting clinical research on the next-generation tumor lytic virus OBP-702.
J Frontier: Corrected Financial Report - 16th Term (2023/06/01－2024/05/31)